Three genome-wide association studies (GWAS) among the European populations conducted during the recent years have found that MTNR1B gene mutations have an association with the increased risk of T2DM, increased fasting plasma glucose (FPG), and decreased insulin secretion [13–15]. Here, INS is linked to type 2 diabetes mellitus.